BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28017373)

  • 1. Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism.
    Harms FL; Girisha KM; Hardigan AA; Kortüm F; Shukla A; Alawi M; Dalal A; Brady L; Tarnopolsky M; Bird LM; Ceulemans S; Bebin M; Bowling KM; Hiatt SM; Lose EJ; Primiano M; Chung WK; Juusola J; Akdemir ZC; Bainbridge M; Charng WL; Drummond-Borg M; Eldomery MK; El-Hattab AW; Saleh MAM; Bézieau S; Cogné B; Isidor B; Küry S; Lupski JR; Myers RM; Cooper GM; Kutsche K
    Am J Hum Genet; 2017 Jan; 100(1):117-127. PubMed ID: 28017373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome.
    Sleven H; Welsh SJ; Yu J; Churchill MEA; Wright CF; Henderson A; Horvath R; Rankin J; Vogt J; Magee A; McConnell V; Green A; King MD; Cox H; Armstrong L; Lehman A; Nelson TN; ; ; Williams J; Clouston P; Hagman J; Németh AH
    Am J Hum Genet; 2017 Jan; 100(1):138-150. PubMed ID: 28017370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
    Chao HT; Davids M; Burke E; Pappas JG; Rosenfeld JA; McCarty AJ; Davis T; Wolfe L; Toro C; Tifft C; Xia F; Stong N; Johnson TK; Warr CG; ; Yamamoto S; Adams DR; Markello TC; Gahl WA; Bellen HJ; Wangler MF; Malicdan MCV
    Am J Hum Genet; 2017 Jan; 100(1):128-137. PubMed ID: 28017372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo variants in
    Tanaka AJ; Cho MT; Willaert R; Retterer K; Zarate YA; Bosanko K; Stefans V; Oishi K; Williamson A; Wilson GN; Basinger A; Barbaro-Dieber T; Ortega L; Sorrentino S; Gabriel MK; Anderson IJ; Sacoto MJG; Schnur RE; Chung WK
    Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel de novo variant in
    Blackburn PR; Barnett SS; Zimmermann MT; Cousin MA; Kaiwar C; Pinto E Vairo F; Niu Z; Ferber MJ; Urrutia RA; Selcen D; Klee EW; Pichurin PN
    Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001743. PubMed ID: 28487885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of individuals with de novo EBF3 variants or deletions.
    Nishi E; Uehara T; Yanagi K; Hasegawa Y; Ueda K; Kaname T; Yamamoto T; Kosaki K; Okamoto N
    Am J Med Genet A; 2021 Oct; 185(10):2913-2921. PubMed ID: 34050706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of clinical features and EBF3 gene variant in a child with hypotonia, ataxia and developmental delay].
    Cong Y; Wang D; Wang H; Xu X; Wu K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1270-1274. PubMed ID: 36317217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive Dysmorphisms.
    Weiss K; Terhal PA; Cohen L; Bruccoleri M; Irving M; Martinez AF; Rosenfeld JA; Machol K; Yang Y; Liu P; Walkiewicz M; Beuten J; Gomez-Ospina N; Haude K; Fong CT; Enns GM; Bernstein JA; Fan J; Gotway G; Ghorbani M; ; van Gassen K; Monroe GR; van Haaften G; Basel-Vanagaite L; Yang XJ; Campeau PM; Muenke M
    Am J Hum Genet; 2016 Oct; 99(4):934-941. PubMed ID: 27616479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.
    Hiatt SM; Thompson ML; Prokop JW; Lawlor JMJ; Gray DE; Bebin EM; Rinne T; Kempers M; Pfundt R; van Bon BW; Mignot C; Nava C; Depienne C; Kalsner L; Rauch A; Joset P; Bachmann-Gagescu R; Wentzensen IM; McWalter K; Cooper GM
    Am J Hum Genet; 2019 Apr; 104(4):701-708. PubMed ID: 30879638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplication/triplication mosaicism of EBF3 and expansion of the EBF3 neurodevelopmental disorder phenotype.
    Ignatius E; Puosi R; Palomäki M; Forsbom N; Pohjanpelto M; Alitalo T; Anttonen AK; Avela K; Haataja L; Carroll CJ; Lönnqvist T; Isohanni P
    Eur J Paediatr Neurol; 2022 Mar; 37():1-7. PubMed ID: 34999443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Missense Substitutions in the Gene Encoding CDK8, a Regulator of the Mediator Complex, Cause a Syndromic Developmental Disorder.
    Calpena E; Hervieu A; Kaserer T; Swagemakers SMA; Goos JAC; Popoola O; Ortiz-Ruiz MJ; Barbaro-Dieber T; Bownass L; Brilstra EH; Brimble E; Foulds N; Grebe TA; Harder AVE; Lees MM; Monaghan KG; Newbury-Ecob RA; Ong KR; Osio D; Reynoso Santos FJ; Ruzhnikov MRZ; Telegrafi A; van Binsbergen E; van Dooren MF; ; van der Spek PJ; Blagg J; Twigg SRF; Mathijssen IMJ; Clarke PA; Wilkie AOM
    Am J Hum Genet; 2019 Apr; 104(4):709-720. PubMed ID: 30905399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coding and noncoding variants in EBF3 are involved in HADDS and simplex autism.
    Padhi EM; Hayeck TJ; Cheng Z; Chatterjee S; Mannion BJ; Byrska-Bishop M; Willems M; Pinson L; Redon S; Benech C; Uguen K; Audebert-Bellanger S; Le Marechal C; Férec C; Efthymiou S; Rahman F; Maqbool S; Maroofian R; Houlden H; Musunuri R; Narzisi G; Abhyankar A; Hunter RD; Akiyama J; Fries LE; Ng JK; Mehinovic E; Stong N; Allen AS; Dickel DE; Bernier RA; Gorkin DU; Pennacchio LA; Zody MC; Turner TN
    Hum Genomics; 2021 Jul; 15(1):44. PubMed ID: 34256850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum.
    Konrad EDH; Nardini N; Caliebe A; Nagel I; Young D; Horvath G; Santoro SL; Shuss C; Ziegler A; Bonneau D; Kempers M; Pfundt R; Legius E; Bouman A; Stuurman KE; Õunap K; Pajusalu S; Wojcik MH; Vasileiou G; Le Guyader G; Schnelle HM; Berland S; Zonneveld-Huijssoon E; Kersten S; Gupta A; Blackburn PR; Ellingson MS; Ferber MJ; Dhamija R; Klee EW; McEntagart M; Lichtenbelt KD; Kenney A; Vergano SA; Abou Jamra R; Platzer K; Ella Pierpont M; Khattar D; Hopkin RJ; Martin RJ; Jongmans MCJ; Chang VY; Martinez-Agosto JA; Kuismin O; Kurki MI; Pietiläinen O; Palotie A; Maarup TJ; Johnson DS; Venborg Pedersen K; Laulund LW; Lynch SA; Blyth M; Prescott K; Canham N; Ibitoye R; Brilstra EH; Shinawi M; Fassi E; ; Sticht H; Gregor A; Van Esch H; Zweier C
    Genet Med; 2019 Dec; 21(12):2723-2733. PubMed ID: 31239556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.
    Machol K; Rousseau J; Ehresmann S; Garcia T; Nguyen TTM; Spillmann RC; Sullivan JA; Shashi V; Jiang YH; Stong N; Fiala E; Willing M; Pfundt R; Kleefstra T; Cho MT; McLaughlin H; Rosello Piera M; Orellana C; Martínez F; Caro-Llopis A; Monfort S; Roscioli T; Nixon CY; Buckley MF; Turner A; Jones WD; van Hasselt PM; Hofstede FC; van Gassen KLI; Brooks AS; van Slegtenhorst MA; Lachlan K; Sebastian J; Madan-Khetarpal S; Sonal D; Sakkubai N; Thevenon J; Faivre L; Maurel A; Petrovski S; Krantz ID; Tarpinian JM; Rosenfeld JA; Lee BH; ; Campeau PM
    Am J Hum Genet; 2019 Jan; 104(1):164-178. PubMed ID: 30580808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo SOX6 Variants Cause a Neurodevelopmental Syndrome Associated with ADHD, Craniosynostosis, and Osteochondromas.
    Tolchin D; Yeager JP; Prasad P; Dorrani N; Russi AS; Martinez-Agosto JA; Haseeb A; Angelozzi M; Santen GWE; Ruivenkamp C; Mercimek-Andrews S; Depienne C; Kuechler A; Mikat B; Ludecke HJ; Bilan F; Le Guyader G; Gilbert-Dussardier B; Keren B; Heide S; Haye D; Van Esch H; Keldermans L; Ortiz D; Lancaster E; Krantz ID; Krock BL; Pechter KB; Arkader A; Medne L; DeChene ET; Calpena E; Melistaccio G; Wilkie AOM; Suri M; Foulds N; ; Begtrup A; Henderson LB; Forster C; Reed P; McDonald MT; McConkie-Rosell A; Thevenon J; Le Tanno P; Coutton C; Tsai ACH; Stewart S; Maver A; Gorazd R; Pichon O; Nizon M; Cogné B; Isidor B; Martin-Coignard D; Stoeva R; Lefebvre V; Le Caignec C
    Am J Hum Genet; 2020 Jun; 106(6):830-845. PubMed ID: 32442410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo variants in CDK13 associated with syndromic ID/DD: Molecular and clinical delineation of 15 individuals and a further review.
    van den Akker WMR; Brummelman I; Martis LM; Timmermans RN; Pfundt R; Kleefstra T; Willemsen MH; Gerkes EH; Herkert JC; van Essen AJ; Rump P; Vansenne F; Terhal PA; van Haelst MM; Cristian I; Turner CE; Cho MT; Begtrup A; Willaert R; Fassi E; van Gassen KLI; Stegmann APA; de Vries BBA; Schuurs-Hoeijmakers JHM
    Clin Genet; 2018 May; 93(5):1000-1007. PubMed ID: 29393965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in HIVEP2 are associated with developmental delay, intellectual disability, and dysmorphic features.
    Steinfeld H; Cho MT; Retterer K; Person R; Schaefer GB; Danylchuk N; Malik S; Wechsler SB; Wheeler PG; van Gassen KL; Terhal PA; Verhoeven VJ; van Slegtenhorst MA; Monaghan KG; Henderson LB; Chung WK
    Neurogenetics; 2016 Jul; 17(3):159-64. PubMed ID: 27003583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalent missense variant in the FOXP2 and FOXP1 transcription factors causes distinct neurodevelopmental disorders.
    Sollis E; Deriziotis P; Saitsu H; Miyake N; Matsumoto N; Hoffer MJV; Ruivenkamp CAL; Alders M; Okamoto N; Bijlsma EK; Plomp AS; Fisher SE
    Hum Mutat; 2017 Nov; 38(11):1542-1554. PubMed ID: 28741757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.